Welcome to the third edition of a special publication dedicated to leadership. We hope that you will find this to be a useful resource to help advance your career and enhance your impact as a leader. The content is an encapsulation of the HBA’s Annual Leadership Conference and provides a window into limitless leadership offerings that the HBA provides to thousands of women across the United States and Europe.
Conventional wisdom maintains that change is constant, and in the life-sciences industry many of our careers are affected by a myriad of change-factors that are often beyond our control—the economy, regulatory oversight measures, mergers and acquisitions, product approvals, product recalls, management turnover, and so on. Today’s turbulent times test the skills of even the best leaders; but how you weather change and navigate rough corporate waters as a leader, a team member, and employee sets you apart and positions you for personal and professional success.
> READ ONLINEAccording to the most recent report from the Tufts Center for the Study of Drug Development, it still takes an average of 10 to 15 years for an experimental drug to travel from the lab to U.S. patients and on average, it costs a company $1.3 billion to get one new medicine from the laboratory to the hands of the consumer (in 2003, the cost was $897 million). Only five in 5,000 compounds that enter preclinical testing makes it to human testing. Of these five, only one is approved. And once the product reaches the market, a myriad of factors impact adoption and use.
> READ ONLINEExecutive and business mentoring provide guidance and direction to employees as to how to think about business issues and competitiveness by using an exchange of experiences and scenarios that look at issues strategically. Alternatively, coaching is focused on addressing specific development needs, often oriented around skill sets.
> READ ONLINEMore than 20 top-tier workshop leaders covered a range of topics addressing personal development, global issues, leadership, business skills, corporate culture, organizational development, and team building.
> READ ONLINEProviding education is one of the core foundations of the HBA, and in 2009, the organization out did itself: 14 HBA Chapters and Affiliates offered a record-setting 201 programs—37% more programs than in 2008.
> READ ONLINEThe ACE Award builds on the HBA’s tradition of recognizing outstanding performance. The award's purpose is to recognize organizations that offer innovative approaches to the “Advancement, Commitment and Engagement” of women’s careers in the healthcare industry, the core mission of the HBA.
> READ ONLINEThe HBA is renowned for its focus on helping women achieve career excellence, develop leadership proficiency, and build professional networks. During its two and a half-day annual leadership conference in San Francisco, the HBA flexed its professional development muscles to educate, inform, and entertain more than 630 attendees.
> READ ONLINEPublished monthly, with combined July/August and November/December issues, PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic and multifaceted life-sciences industry.
PharmaVOICE reaches more than 17,500 BPA-qualified subscribers with every issue. PharmaVOICE’s unique horizontal editorial approach cuts across industry silos, provides a holistic overview of the life-sciences industry, and addresses a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialogue, initiates debate, and opens the lines of communications to facilitate and improve business-to-business relationships. PharmaVOICE’s unique and in-depth original forums, feature articles, executive bios, and departments are people-focused and audience-driven.
PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of business practices and topics from clinical research through commercialization.